.png?width=150&name=MMS%20logo_without%20Tagline%20(Full%20Color).png "MMS logo_without Tagline (Full Color)")
MMS Holdings Wins 2021 Scrip Award for Best Contract Research Organization
CANTON, Mich. (12/8/2021) – MMS Holdings, a data-focused CRO, is pleased to announce its selection as Best ...
FDA Expedited Program Designations to Support Rare Disease Drug Development
By: Christine Clarke PhD, Senior Medical Writer One in 10 Americans is affected by rare diseases—more than ...
Former Astellas Pharma VP of Biostatistics Joins MMS Holdings
CANTON, Mich. (November 18, 2021) – MMS Holdings – a data-focused CRO – announced this week the addition ...
DETROIT FREE PRESS NAMES MMS A WINNER OF THE MICHIGAN TOP WORKPLACES 2021 AWARD
CANTON, Mich. (11/15/2021) - MMS has been named a 2021 award winner of the Michigan Top Workplaces by the ...
Second Annual Global Champions of Change Competition Winner
By Jim Balcom, Director of Partnerships and IT Governance MMS has just concluded its second annual Global ...
Praxis bioresearch seeks support from MMS for Alzheimers Disease Therapeutics
SACRAMENTO, Calif. (October 28, 2021) – MMS Holdings (MMS) – a data-focused CRO – provided regulatory ...
How to use a Master Protocol to gain Efficiencies in a Clinical Trial
By: Tasnim Hoda, Manager of Regulatory and Medical Writing and Aaron Burr, Senior Medical Writer
Challenges of Rare Disease Drug Development Programs
By: Amanda Beaster, Ph.D.
Tips for Successful Medical Device Development and Approval
By: Gary Pekoe, Senior Medical Writer
How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations
By: Kasim McLain, Manager of Transparency
